NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Stock Information | RedChip

NRX Pharmaceuticals Inc. (NASDAQ: NRXP) Listen to this Section


$1.75
+0.0100 ( +0.58% ) 62.5K

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Market Data


Open


$1.75

Previous close


$1.74

Volume


62.5K

Market cap


$18.51M

Day range


$1.74 - $1.95

52 week range


$1.73 - $7.33

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 24 Feb 28, 2024
8-k 8K-related 16 Feb 14, 2024
8-k 8K-related 16 Feb 14, 2024
8-k 8K-related 15 Feb 02, 2024
8-k 8K-related 14 Jan 23, 2024
3 Insider transactions 1 Jan 16, 2024
8-k 8K-related 14 Dec 29, 2023
pre Proxies and info statements 4 Dec 29, 2023
8-k 8K-related 13 Dec 21, 2023
ars Annual reports 1 Nov 22, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.